Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918851 · ClinicalTrials.gov registry record · Phase 4
VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?
A Phase 4 study of Healthy, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 4
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT02918851 is a Phase 4 study of Healthy that has completed, run by Stony Brook University. The registered enrollment target is 42 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02918851, a Phase 4 study of Healthy, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center, randomized, partially blinded study to determine whether 42-day old red blood cells (RBCs) deliver oxygen as effectively as 7-day old RBCs and also to determine whether transfusion with 28-day old RBCs is non-inferior to 7-day old RBCs with respect to oxygen delivery. In this study, subjects will be randomized to be transfused with 2 units of autologous (one's own) RBCs that are either 7-, 28-, or 42-days old. Endpoints include changes in exercise duration and VO2 max (test of oxygen consumption/delivery) between groups.
Conditions Studied
Interventions
- BIOLOGICAL Transfusion of 7-day stored red blood cells
- BIOLOGICAL Transfusion of 28-day stored red blood cells
- BIOLOGICAL Transfusion of 42-day stored red blood cells
Study Locations (1)
New York
- Stony Brook Medicine - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-11-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02918851
The ClinicalTrials.gov registry entry for NCT02918851 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (94% lower). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Transfusion of 7-day stored red blood cells is the first listed.
NCT02918851 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02918851 about?
NCT02918851 is a clinical study titled "VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?". This is a single-center, randomized, partially blinded study to determine whether 42-day old red blood cells (RBCs) deliver oxygen as effectively as 7-day old RBCs and also to determine whether transfusion with 28-day old RBCs is non-inferior to 7-day old RBCs with respect to oxygen delivery. In th...
What is the current status of trial NCT02918851?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2017-01. Estimated completion is 2019-11-20.
What conditions does trial NCT02918851 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT02918851?
The interventions under investigation include: Transfusion of 7-day stored red blood cells (BIOLOGICAL), Transfusion of 28-day stored red blood cells (BIOLOGICAL), Transfusion of 42-day stored red blood cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT02918851?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02918851 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic Activation
RECRUITING · Phase 4
-
Effects of GH and Lirglutide on AgRP
RECRUITING · Phase 4
-
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
RECRUITING · Phase 4
-
Endothelial Derived Hyperpolarization Factor and Vascular Control
RECRUITING · Phase 4
-
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
ACTIVE NOT RECRUITING · Phase 4
-
Pharmacokinetics of Transdermal Metronidazole
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.